Barclays Maintains Overweight on Aptiv, Lowers Price Target to $65

Benzinga Newsdesk www.benzinga.com Negative 83.0%

Neg 83% Neu 0% Pos 0%

Barclays analyst Dan Levy maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $73 to $65.

Comments

No comments yet. Be the first!